Misfeldt Dayton 4
4 · SUNESIS PHARMACEUTICALS INC · Filed Jan 3, 2019
Insider Transaction Report
Form 4
Misfeldt Dayton
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2018-12-31+200,000→ 200,000 totalExercise: $0.42Exp: 2028-12-31→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests monthly over six (6) months in equal monthly installments subject to optionee's continuing service to the Company.